Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-21

Clinical Trial Update: The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization. [Phase 2]

View source ↗

Summary

Phase 2 trial investigating whether probiotics can reduce antepartum Group B Streptococcus colonization; results posted in 2024 with unknown current status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Marquette University | Conditions: Group B Streptococcus Carrier in Childbirth, Gastrointestinal Symptoms | Phase 2 | Status: UNKNOWN | Results posted: 2024-03-21